Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -14338.00x is 161% below its 1-year average of -5489.15x, near the low end of its 1-year range (-14338.00x–-2257.00x).
As of the fiscal period ended Friday, December 31, 2021. 161.21% below its 12-month average of -5489.15x.
Reported quarterly interest coverage; no daily interpolation. Q4 FY2021 (2021-12-31): -14338.00x.
INTEREST COVERAGE RATIO
-14338.00x
INTEREST COVERAGE RATIO AVG TTM
-5489.15x
INTEREST COVERAGE RATIO AVG 3Y
N/A
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-161.21%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.38x
median of 528 covered companies
CURRENT VS SECTOR MEDIAN
-224809.80%
vs the sector median at left
Korsana Biosciences, Inc.
Market Cap
$145.68M
Interest Coverage Ratio
-14338.00x
TTM Avg
-5489.15x
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$145.70M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$145.96M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$145.29M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$146.62M
Interest Coverage Ratio
-29.32x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$146.67M
Interest Coverage Ratio
-64.93x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$146.82M
Interest Coverage Ratio
-7.96x
TTM Avg
23.57x
3Y Avg
23.57x
5Y Avg
23.57x
Market Cap
$146.82M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$144.06M
Interest Coverage Ratio
-8.06x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Korsana Biosciences, Inc. (KRSA) | $145.68M | -14338.00x | -5489.15x | N/A | N/A |
| NervGen Pharma Corp. Common stock (NGEN)vs › | $145.70M | N/A | N/A | N/A | N/A |
| Anavex Life Sciences Corp. (AVXL)vs › | $145.96M | N/A | N/A | N/A | N/A |
| Protara Therapeutics, Inc. (TARA)vs › | $145.29M | N/A | N/A | N/A | N/A |
| Acumen Pharmaceuticals, Inc. (ABOS)vs › | $146.62M | -29.32x | N/A | N/A | N/A |
| ALX Oncology Holdings Inc. (ALXO)vs › | $146.67M | -64.93x | N/A | N/A | N/A |
| Codexis, Inc. (CDXS)vs › | $146.82M | -7.96x | 23.57x | 23.57x | 23.57x |
| Voyager Therapeutics, Inc. (VYGR)vs › | $146.82M | N/A | N/A | N/A | N/A |
| Fortress Biotech, Inc. (FBIOP)vs › | $144.06M | -8.06x | N/A | N/A | N/A |
| Nyxoah S.A. (NYXH)vs › | $142.10M | -49.05x | N/A | N/A | N/A |
Interest Coverage
-14338.0x
Debt/Equity
0.00
Current Ratio
0.82
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2021-12-31 | -14338.00x |
| 2021-09-30 | -2257.00x |
| 2021-06-30 | -2696.00x |
| 2021-03-31 | -3348.75x |
| 2020-12-31 | -4806.00x |
